Double NF1 Inactivation Affects Adrenocortical Function in NF1Prx1 Mice and a Human Patient
暂无分享,去创建一个
S. Mundlos | H. Morreau | C. Ott | V. Mautner | S. Tinschert | J. Kühnisch | A. Harder | A. Huebner | M. von der Hagen | F. Hes | D. Hartl | M. Kolanczyk | M. Osswald | K. Kobus | D. Emmerich
[1] B. Korf. Chapter 39 – Neurofibromatosis , 2013 .
[2] K. Kosaki,et al. Persistent Hypertension Despite Successful Dilation of a Stenotic Renal Artery in a Boy With Neurofibromatosis Type 1 , 2013, American journal of medical genetics. Part A.
[3] E. Letouzé,et al. Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma. , 2012, Human molecular genetics.
[4] C. Stratakis,et al. The cAMP pathway and the control of adrenocortical development and growth , 2012, Molecular and Cellular Endocrinology.
[5] M. Selbach,et al. Global quantification of mammalian gene expression control , 2011, Nature.
[6] P. Robinson,et al. Neurofibromin (Nf1) is required for skeletal muscle development. , 2011, Human molecular genetics.
[7] G. H. Vries,et al. Aberrant cAMP Metabolism in NF1 Malignant Peripheral Nerve Sheath Tumor Cells , 2011, Neurochemical Research.
[8] D. Horn,et al. Osteopoikilosis and multiple exostoses caused by novel mutations in LEMD3 and EXT1 genes respectively - coincidence within one family , 2010, BMC Medical Genetics.
[9] S. Mundlos,et al. Deletions of the RUNX2 gene are present in about 10% of individuals with cleidocranial dysplasia , 2010, Human mutation.
[10] Y. Kloog,et al. The pre-GAP-related domain of neurofibromin regulates cell migration through the LIM kinase/cofilin pathway , 2009, Molecular and Cellular Neuroscience.
[11] V. Riccardi. Neurofibromatosis type 1 is a disorder of dysplasia: the importance of distinguishing features, consequences, and complications. , 2009, Birth defects research. Part A, Clinical and molecular teratology.
[12] G. Bates,et al. A Large Number of Protein Expression Changes Occur Early in Life and Precede Phenotype Onset in a Mouse Model for Huntington Disease*S , 2009, Molecular & Cellular Proteomics.
[13] D. Gutmann,et al. Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation. , 2008, Cancer research.
[14] A. Hoeflich,et al. Mechanisms of adrenal gland growth: signal integration by extracellular signal regulated kinases1/2. , 2008, Journal of molecular endocrinology.
[15] D. Gutmann,et al. Neurofibromin regulates somatic growth through the hypothalamic-pituitary axis. , 2008, Human molecular genetics.
[16] E. Petty,et al. The role of steroid hormones in the NF1 phenotype: Focus on pregnancy , 2008, American journal of medical genetics. Part A.
[17] A. Brash,et al. Routes to 4-Hydroxynonenal: Fundamental Issues in the Mechanisms of Lipid Peroxidation* , 2008, Journal of Biological Chemistry.
[18] M. Logan,et al. Visualizing the lateral somitic frontier in the Prx1Cre transgenic mouse , 2008, Journal of anatomy.
[19] O. Kovzun,et al. [The influence of protein kinases ERK, JNK and nuclear transcriptional factor c-JUN on corticotropin signal transduction in adrenocortical cells]. , 2008, Ukrains'kyi biokhimichnyi zhurnal.
[20] Joachim Klose,et al. Transcriptome and proteome analysis of early embryonic mouse brain development , 2008, Proteomics.
[21] S. Galli,et al. A Mitochondrial Kinase Complex Is Essential to Mediate an ERK1/2-Dependent Phosphorylation of a Key Regulatory Protein in Steroid Biosynthesis , 2008, PloS one.
[22] L. Luo,et al. A global double‐fluorescent Cre reporter mouse , 2007, Genesis.
[23] Z. Granot,et al. Turnover of mitochondrial steroidogenic acute regulatory (StAR) protein by Lon protease: the unexpected effect of proteasome inhibitors. , 2007, Molecular endocrinology.
[24] A. Hoeflich,et al. Growth analysis of the mouse adrenal gland from weaning to adulthood: time- and gender-dependent alterations of cell size and number in the cortical compartment. , 2007, American journal of physiology. Endocrinology and metabolism.
[25] Joachim Klose,et al. High MS‐compatibility of silver nitrate‐stained protein spots from 2‐DE gels using ZipPlates and AnchorChips for successful protein identification , 2007, Electrophoresis.
[26] S. Mundlos,et al. Multiple roles for neurofibromin in skeletal development and growth. , 2007, Human molecular genetics.
[27] I. Bossis,et al. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia , 2006, Nature Genetics.
[28] I. Huhtaniemi,et al. Molecular mechanisms of insulin-like growth factor-I mediated regulation of the steroidogenic acute regulatory protein in mouse leydig cells. , 2006, Molecular endocrinology.
[29] H. Saya,et al. The Neurofibromatosis Type 1 Gene Product Neurofibromin Enhances Cell Motility by Regulating Actin Filament Dynamics via the Rho-ROCK-LIMK2-Cofilin Pathway* , 2005, Journal of Biological Chemistry.
[30] B. G. Saruhan,et al. Effect of ovariectomy and of estrogen treatment on the adrenal gland and body weight in rats. , 2005, Saudi medical journal.
[31] C. Johannessen,et al. The NF1 tumor suppressor critically regulates TSC2 and mTOR. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Bertherat,et al. Decreased expression of cyclic adenosine monophosphate-regulated aldose reductase (AKR1B1) is associated with malignancy in human sporadic adrenocortical tumors. , 2004, The Journal of clinical endocrinology and metabolism.
[33] G. Di Salvo,et al. Blood pressure and cardiovascular involvement in children with neurofibromatosis type1 , 2004, Pediatric Nephrology.
[34] G. Di Salvo,et al. Arterial distensibility and ambulatory blood pressure monitoring in young patients with neurofibromatosis type 1. , 2001, American journal of hypertension.
[35] J. Marth,et al. Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. , 2001, Genes & development.
[36] T. Roberts,et al. Schwann Cell Proliferative Responses to cAMP andNf1 Are Mediated by Cyclin D1 , 2001, The Journal of Neuroscience.
[37] C. Aigueperse,et al. Physiological functions and hormonal regulation of mouse vas deferens protein (AKR1B7) in steroidogenic tissues. , 2001, Chemico-biological interactions.
[38] C. Stratakis,et al. Mutations of the gene encoding the protein kinase A type I-α regulatory subunit in patients with the Carney complex , 2000, Nature Genetics.
[39] K. McCarthy,et al. Retroviral Inhibition of cAMP-Dependent Protein Kinase Inhibits Myelination But Not Schwann Cell Mitosis Stimulated by Interaction with Neurons , 2000, The Journal of Neuroscience.
[40] M. Alessandri,et al. A case of neurofibromatosis type 1 with an aldosterone‐producing adenoma of the adrenal , 1999, Journal of internal medicine.
[41] W. Miller,et al. Molecular pathology and mechanism of action of the steroidogenic acute regulatory protein, StARProceedings of Xth International Congress on Hormonal Steroids, Quebec, Canada, 17–21 June 1998. , 1999, The Journal of Steroid Biochemistry and Molecular Biology.
[42] H. Watari,et al. Phosphorylation of Steroidogenic Acute Regulatory Protein (StAR) Modulates Its Steroidogenic Activity* , 1997, The Journal of Biological Chemistry.
[43] J. Charrow,et al. Neurofibromatosis type I and precocious puberty: beyond the chasm. , 1997, The Journal of pediatrics.
[44] H. Simonsz,et al. Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1. , 1997, Pediatrics.
[45] G. Nussdorfer,et al. Effects of sex hormones on the steroidogenic activity of dispersed adrenocortical cells of the rat adrenal cortex. , 1995, Life sciences.
[46] M. Zöller,et al. Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden. , 1995, Acta dermato-venereologica.
[47] F. Collins,et al. Loss of neurofibromin in adrenal gland tumors from patients with neurofibromatosis type I , 1994, Genes, chromosomes & cancer.
[48] M. Daston,et al. Neurofibromin, a predominantly neuronal GTPase activating protein in the adult, is ubiquitously expressed during development , 1992, Developmental dynamics : an official publication of the American Association of Anatomists.
[49] M. Seldin,et al. Different isozymes of mouse 11 beta-hydroxylase produce mineralocorticoids and glucocorticoids. , 1991, Molecular endocrinology.
[50] N. Taylor,et al. Adrenal Cortical Adenoma in a 13‐Year‐Old Girl with Neurofibromatosis , 1989, Acta paediatrica Scandinavica.
[51] G. Tsujimoto,et al. Salt-sensitive hypertension in circadian clock–deficient Cry-null mice involves dysregulated adrenal Hsd3b6 , 2010, Nature Medicine.
[52] D. Viskochil,et al. Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications. , 2010, Neurosurgical focus.
[53] J. Poderoso,et al. Detection of a mitochondrial kinase complex that mediates PKA-MEK-ERK-dependent phosphorylation of mitochondrial proteins involved in the regulation of steroid biosynthesis. , 2009, Methods in enzymology.
[54] L. Berrizbeitia. Mutation in PDE8B, a Cyclic AMP-Specific Phosphodiesterase in Adrenal Hyperplasia , 2008 .
[55] S. Lumbroso,et al. McCune-Albright syndrome: molecular genetics. , 2002, Journal of pediatric endocrinology & metabolism : JPEM.
[56] R. Virdis,et al. Neurofibromatosis Type 1 and Precocious Puberty , 2000, Journal of pediatric endocrinology & metabolism : JPEM.
[57] Philippe Soriano. Generalized lacZ expression with the ROSA26 Cre reporter strain , 1999, Nature Genetics.
[58] K. Reilly,et al. Molecular and Cellular Pathobiology the Neurofibromatosis Type 1 Tumor Suppressor Controls Cell Growth by Regulating Signal Transducer and Activator of Transcription-3 Activity in Vitro and in Vivo , 2022 .